New test could help young women beat uterine cancer and still have babies
NCT ID NCT06799624
Summary
This study aims to see if analyzing the genetic makeup of a uterine tumor can help doctors better predict which young women will respond well to fertility-preserving hormone treatments. It will enroll 100 women aged 18-45 with early-stage endometrial cancer who wish to have children in the future. The goal is to use this 'molecular classification' to personalize treatment, potentially improving cancer outcomes while preserving the ability to get pregnant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Milan, Michigan, 20133, Italy
Conditions
Explore the condition pages connected to this study.